CYP2B6 and diabetes mellitus: Berberine is the main pharmacologically active component of C. chinensis is involved in the regulation of P450 gene expression, which can also improve the chronic inflammatory state of type 2 diabetes mellitus, change or stimulate the transformation of brown adipose tissue to white, promote energy metabolism, improve insulin resistance and improve glucose metabolism (24, –, 26).